Company Overview of MithraGen, Inc.
MithraGen, Inc. develops immunotherapies for T and B cells for the treatment and prevention of cancers and infectious diseases. It offers RetroVax, a product platform technology, which turns antigen containing class I and II epitopes into an immunostimulant. The company also provides RetroVax therapeutic vaccines. MithraGen, Inc. was formerly known as MithraTech, Inc. The company is based in Houston, Texas.
8030 El Rio
Houston, TX 77054
Key Executives for MithraGen, Inc.
Similar Private Companies By Industry
|AstraZeneca R&D Boston Inc.||United States|
|Oncocidex, Inc.||United States|
|AngioGenex, Inc.||United States|
|InterNutria, Inc.||United States|
|Oceana Therapeutics, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact MithraGen, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.